221 related articles for article (PubMed ID: 17004522)
1. Dipyrone (metamizole) use in the United States: a lethal tango?
Moorman J
South Med J; 2006 Sep; 99(9):916. PubMed ID: 17004522
[No Abstract] [Full Text] [Related]
2. Neutropenia, agranulocytosis and dipyrone.
Hamerschlak N; Cavalcanti AB
Sao Paulo Med J; 2005 Sep; 123(5):247-9. PubMed ID: 16358101
[TBL] [Abstract][Full Text] [Related]
3. [Surgery, dipyrone, and agranulocytosis in Latin America].
Sánchez Medal L
Sangre (Barc); 1997 Oct; 42(5):343-4. PubMed ID: 9424731
[No Abstract] [Full Text] [Related]
4. A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland.
Maj S; Centkowski P
Med Sci Monit; 2004 Sep; 10(9):PI93-5. PubMed ID: 15328493
[TBL] [Abstract][Full Text] [Related]
5. Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child.
Işık M; Kaya Z; Belen FB; Aktaş AT; Tezer H; Gürsel T
J Pediatr Hematol Oncol; 2014 Jan; 36(1):e46-8. PubMed ID: 23007418
[TBL] [Abstract][Full Text] [Related]
6. The incidence of metamizole sodium-induced agranulocytosis in Poland.
Maj S; Lis Y
J Int Med Res; 2002; 30(5):488-95. PubMed ID: 12449518
[TBL] [Abstract][Full Text] [Related]
7. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
Hedenmalm K; Spigset O
Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373
[TBL] [Abstract][Full Text] [Related]
8. [Agranulocytosis from metamizole: a potential problem for the British population].
Mérida Rodrigo L; Faus Felipe V; Poveda Gómez F; García Alegría J
Rev Clin Esp; 2009 Apr; 209(4):176-9. PubMed ID: 19457324
[TBL] [Abstract][Full Text] [Related]
9. [Dipyrone, the controversy].
Borbolla Escoboza JF; Collados Larumbe MT
Rev Invest Clin; 1994; 46(1):73-4. PubMed ID: 8079069
[No Abstract] [Full Text] [Related]
10. Dipyrone and blood dyscrasia revisited: "non-evidence based medicine".
Benseñor IM
Sao Paulo Med J; 2005 May; 123(3):99-100. PubMed ID: 16021269
[No Abstract] [Full Text] [Related]
11. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
Lampl C; Likar R
Schmerz; 2014 Dec; 28(6):584-90. PubMed ID: 25199942
[TBL] [Abstract][Full Text] [Related]
12. [Severe thrombocytopenia and agranulocytosis associated with metamizole].
Fernández García PL; Ibáñez Camacho MF; López Pérez E
Med Clin (Barc); 2016 Oct; 147(8):e43-e44. PubMed ID: 27450174
[No Abstract] [Full Text] [Related]
13. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.
Bäckström M; Hägg S; Mjörndal T; Dahlqvist R
Pharmacoepidemiol Drug Saf; 2002; 11(3):239-45. PubMed ID: 12051124
[TBL] [Abstract][Full Text] [Related]
14. Chronic use of metamizole: not so safe after all?
Vuik FE; Koehestanie P; Herbers AH; Terhaar Sive Droste JS
Neth J Med; 2017 Mar; 75(2):81-83. PubMed ID: 28276328
[TBL] [Abstract][Full Text] [Related]
15. Metamizole use by Latino immigrants: a common and potentially harmful home remedy.
Bonkowsky JL; Frazer JK; Buchi KF; Byington CL
Pediatrics; 2002 Jun; 109(6):e98. PubMed ID: 12042592
[TBL] [Abstract][Full Text] [Related]
16. To use or not to use dipyrone? Or maybe, Central Station versus ER? That is the question.
Benseñor IM
Sao Paulo Med J; 2001 Nov; 119(6):190-1. PubMed ID: 11723531
[No Abstract] [Full Text] [Related]
17. [Dual agranulocytosis episode likely resulting from metamizole use].
Hemmersbach-Miller M; Conde Martel A; Acosta Artiles M; Suárez Ortega S
Farm Hosp; 2005 Mar; 29(2):148-50. PubMed ID: 16045431
[No Abstract] [Full Text] [Related]
18. Dipyrone and agranulocytosis: what is the risk?
Edwards JE; McQuay HJ
Lancet; 2002 Nov; 360(9344):1438. PubMed ID: 12433507
[No Abstract] [Full Text] [Related]
19. Dipyrone and agranulocytosis: what is the risk?
Schönhöfer P; Offerhaus L; Herxheimer A
Lancet; 2003 Mar; 361(9361):968-9. PubMed ID: 12648993
[No Abstract] [Full Text] [Related]
20. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study.
Huber M; Andersohn F; Sarganas G; Bronder E; Klimpel A; Thomae M; Konzen C; Kreutz R; Garbe E
Eur J Clin Pharmacol; 2015 Feb; 71(2):219-27. PubMed ID: 25378038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
